Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 88-3812342 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The rapidly emerging antiviral drug development initiative (Readdi) is a nonprofit biotechnology organization dedicated to preventing global catastrophes caused by viruses. It plays a clear, specific and central role in the widely accepted three-pronged pandemic preparedness approach involving diagnostics, therapeutics and vaccines. Readdi develops therapeutics.
Total Revenue
$624K
FY2024
Total Expenses
$1.1M
FY2024
Net Assets
$1.1M
Program Ratio
30.6%
expenses on programs
Employees
0
Volunteers
6
Board Members
9
Voting
5
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.